⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AARD News
Aardvark Therapeutics, Inc. Common Stock
AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
AARD
Pomerantz LLP Launches Securities Lawsuit Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
AARD LAWSUIT ALERT: Levi & Korsinsky Notifies Aardvark Therapeutics, Inc. Investors - Lead Plaintiff Deadline October 13, 2026
accessnewswire.com
AARD
Lost Money on Aardvark Therapeutics, Inc. (AARD)? Urged to Join Class Action Before October 13, 2026 - Contact Levi & Korsinsky
accessnewswire.com
AARD
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Aardvark Therapeutics, Inc. (AARD) Investors of October 13, 2026 Deadline
accessnewswire.com
AARD
AARD DEADLINE NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AARD
accessnewswire.com
AARD
Pomerantz LLP Files Investor Lawsuit Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
AARD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AARD
Pomerantz LLP Launches Class Action Litigation Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
Aardvark Therapeutics, Inc. (AARD) Lawsuit – Investors Urged to Contact Levi & Korsinsky Before October 13, 2026
accessnewswire.com
AARD